Hetlioz

The FDA ( Food and Drug Administration ) has approved Hetlioz ( Tasimelteon ), a melatonin receptor agonist, to treat...


Hetlioz, a melatonin receptor agonist, is indicated for the treatment of non-24-hour sleep-wake disorder ( Non-24 ).Important safety informationHetlioz may...


The Food and Drug Administration's ( FDA ) Peripheral and Central Nervous System Drugs Advisory Committee ( Advisory Committee )...


Additional data were presented at ENDO 2013, the Endocrine Society's 95th Annual Meeting, demonstrating that Tasimelteon ( Hetlioz ) can...